Methods for treating metabolic syndrome
OwnerKristen Beckman, Thomas McDonnell +1inventors
InventorsKristen Beckman, Thomas McDonnell, Cheryl Renz
Life of this patent
Estimating the term…
Abstract
The invention pertains, at least in part, to a method for treating metabolic syndrome in a subject. The method includes administering to a subject an effective amount of a compound of formula (I). The compound of formula (I) is: wherein R1 and R2 are independently H or methyl, and enantiomers and pharmaceutically acceptable salts thereof.
Claims20
A method for treating metabolic syndrome in a subject, comprising:
- preselecting a subject suffering from metabolic syndrome;
- administering to said subject an effective amount of a compound of formula (I), such that said subject is treated for said metabolic syndrome, wherein said compound of formula (I) is:
- wherein R1 and R2 are independently H or methyl, and enantiomers and pharmaceutically acceptable salts thereof.
A method for treating metabolic syndrome in a subject, comprising:
- administering to said subject an effective amount of a compound of formula (I), such that said subject is treated for said metabolic syndrome, wherein said compound of formula (I) is:
- wherein R1 and R2 are independently H or methyl, and enantiomers and pharmaceutically acceptable salts thereof.
A method for treating metabolic syndrome in a subject, comprising:
- preselecting a subject suffering from three or more symptoms of metabolic syndrome;
- administering to said subject an effective amount of a compound of formula (I), such that said subject is treated for said metabolic syndrome, wherein said compound of formula (I) is:
- wherein R1 and R2 are independently H or methyl, and enantiomers and pharmaceutically acceptable salts thereof.
A packaged pharmaceutical composition, comprising an effective amount of a compound of formula (I) for the treatment of metabolic syndrome and directions for using said compound to treat metabolic syndrome, wherein said compound of formula (I) is:
- wherein R1 and R2 are independently H or methyl, and enantiomers and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.